Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Trefoil Therapeutics

Request full access

Trefoil was founded to bring forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases

San Diego, United StatesFounded 2014Biotech & Life Sciences

About Trefoil Therapeutics

Trefoil Therapeutics is a biotechnology company specializing in the development of regenerative pharmacologic treatments for corneal diseases. The company's core technology platform is based on engineered fibroblast growth factor 1 (eFGF1), which is designed to stimulate the proliferation and migration of corneal endothelial cells. Trefoil's lead candidate, TTHX1114, is an engineered form of FGF1 that is being developed as an intracameral injection. This treatment aims to address endothelial dystrophy, a leading cause of cornea transplantation surgeries, by promoting the healing of corneal endothelial lesions.

Trefoil operates in the biopharmaceutical market, targeting ophthalmologists and healthcare providers who treat corneal diseases. The company's business model involves the research, development, and eventual commercialization of its proprietary treatments. Revenue is generated through the sale of these pharmacologic treatments, as well as potential partnerships and licensing agreements with larger pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
11
Open positions
None listed
Dealroom signal
67.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Dec 2021 $28M $112M Hatteras Venture Partners ↗
FundingOther financing Jan 2020 $0 — Solasta Ventures —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Trefoil Therapeutics website traffic

Latest recorded traffic for Trefoil Therapeutics is 1K monthly website visits, down 37.5% over the last three months. Trefoil Therapeutics's team grew 0% over the past year.

Latest monthly visits1K 3-month web change-37.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Trefoil Therapeutics in the San Diego ecosystem

Live from Dealroom

The Trefoil Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Hatteras Venture Partners
  • Aju IB Investment
  • ExSight Capital
  • Bios Partners
  • Correlation Ventures

Other known investors4 additional known investors

  • Florida State University
  • Solasta Ventures
  • University of California, Irvine
  • Washington University in St. Louis
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Trefoil Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Trefoil Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.